Cargando…

Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population

Immunologic correlates of protection can be used to infer vaccine efficacy for populations in which challenge trials or field studies are infeasible. In a recent cholera challenge trial (W. H. Chen et al., Clin Infect Dis 62:1329–1335, 2016, https://doi.org/10.1093/cid/ciw145), 134 North American ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haney, Douglas J., Lock, Michael D., Simon, Jakub K., Harris, Jason, Gurwith, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Vaccines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583470/ https://www.ncbi.nlm.nih.gov/pubmed/28566334 http://dx.doi.org/10.1128/CVI.00098-17

Ejemplares similares

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
por: Sow, Samba O., et al.
Publicado: (2017)

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers
por: Islam, Kamrul, et al.
Publicado: (2018)

Correlates of Protection for Cholera
por: Iyer, Anita S, et al.
Publicado: (2021)

Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine
por: Chac, Denise, et al.
Publicado: (2021)

Development of a Monoclonal Antibody to a Vibriophage as a Proxy for Vibrio cholerae Detection
por: Sayeed, Md Abu, et al.
Publicado: (2022)

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
por: Dunning, Andrew J., et al.
Publicado: (2016)

The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
por: Wegmann, Frank, et al.
Publicado: (2015)

Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera
por: Kaisar, M. Hasanul, et al.
Publicado: (2021)

Protective Inoculation against Cholera
Publicado: (1913)

Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites
por: Hofmeyer, Kimberly A., et al.
Publicado: (2016)

Estimating cholera incidence with cross-sectional serology
por: Azman, Andrew S., et al.
Publicado: (2019)

Neutrophils Are Central to Antibody-Mediated Protection against Genital Chlamydia
por: Naglak, Elizabeth K., et al.
Publicado: (2017)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
por: Karnasuta, Chitraporn, et al.
Publicado: (2017)

Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility
por: Charles, Richelle C., et al.
Publicado: (2020)

Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms
por: McNee, Adam, et al.
Publicado: (2020)

GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis
por: King, Thomas H., et al.
Publicado: (2017)

Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model
por: Vianzon, Vianca, et al.
Publicado: (2017)

Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller
por: Ringel, Oliver, et al.
Publicado: (2018)

Vaccine hesitancy: the next challenge in the fight against COVID-19
por: Dror, Amiel A., et al.
Publicado: (2020)

Current views and challenges on clinical cholera
por: Somboonwit, Charurut, et al.
Publicado: (2017)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination
por: Levine, Min Z., et al.
Publicado: (2016)

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms
por: McCraw, Dustin M., et al.
Publicado: (2016)

Inoculation against Cholera
Publicado: (1892)

Precaution against Cholera
Publicado: (1885)

Fight against cholera outbreak, efforts and challenges in Malawi
por: Miggo, Mictum, et al.
Publicado: (2023)

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
por: Riddle, Mark S., et al.
Publicado: (2016)

Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines
por: Tejedor, Juan Carlos, et al.
Publicado: (2016)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
por: Karasavvas, Nicos, et al.
Publicado: (2015)

Meeting Cholera's Challenge to Haiti and the World: A Joint Statement on Cholera Prevention and Care
por: Farmer, Paul, et al.
Publicado: (2011)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2–9 Years of Age: A Phase III, Randomized Study
por: Baccarini, Carmen I., et al.
Publicado: (2020)

A dysbiotic gut microbiome suppresses antibody mediated-protection against Vibrio cholerae
por: Macbeth, John C., et al.
Publicado: (2021)

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice
por: Griffiths, Kristin L., et al.
Publicado: (2013)

Sanitary Inspection: Cleanliness Is the Best Protection against Cholera
Publicado: (1885)

A Novel Murine Cytomegalovirus Vaccine Vector Protects against Mycobacterium tuberculosis
por: Beverley, Peter C. L., et al.
Publicado: (2014)

A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge
por: Chan, Win-Yan, et al.
Publicado: (2019)

The politics of vaccine hesitancy in Europe
por: Stoeckel, Florian, et al.
Publicado: (2022)

Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children
por: Claeys, Carine, et al.
Publicado: (2019)

Vibriocidal Titer and Protection From Cholera in Children
por: Ritter, Alaina S, et al.
Publicado: (2019)

Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy
por: Palamenghi, Lorenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5h9ecc0a2t531fh4altkbb59ku